Bata India Q4 Review - Expect Delayed Sales Recovery: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Dolat Capital Report.Bata India Ltd.’s Q4 FY21 revenues came below our estimate as we anticipated better revenue traction due to improved business conditions.We believe that the sales performance would remain low in the coming quarters due to nationwide lock downs and anticipated further delays in opening of malls.Nevertheless, over 12-18 months, we believe that the continuous store additions, new promotional activities and procuring institutional contracts would help the company to recover from lull sales growth.Post re-opening of markets, most of the retail businesses have reached pre-Covid-19 level.With gradual re-opening of schools and offices, we believe that the company would also regain lost momentum..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Bata India Q4 Review - Expect Delayed Sales Recovery: Dolat Capital

Bata India Q4 Review - Expect Delayed Sales Recovery: Dolat Capital

Choose a plan